BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,938,176 | -16.4% | 3,151,515 | +1.0% | 0.10% | -16.4% |
| Q2 2023 | $142,194,491 | +11.4% | 3,121,038 | -0.8% | 0.12% | +8.0% |
| Q1 2023 | $127,658,544 | -25.5% | 3,147,400 | -6.3% | 0.11% | -22.6% |
| Q4 2022 | $171,241,819 | -11.1% | 3,359,659 | -6.0% | 0.15% | -17.5% |
| Q3 2022 | $192,540,000 | -17.4% | 3,574,825 | -1.5% | 0.18% | -18.8% |
| Q2 2022 | $233,174,000 | -18.8% | 3,630,304 | -2.0% | 0.22% | -2.2% |
| Q1 2022 | $287,193,000 | -11.4% | 3,703,807 | -1.9% | 0.22% | +2.8% |
| Q4 2021 | $324,152,000 | +3.5% | 3,776,233 | -3.0% | 0.22% | -7.3% |
| Q3 2021 | $313,053,000 | +0.0% | 3,892,240 | +0.1% | 0.23% | -0.4% |
| Q2 2021 | $312,951,000 | -6.1% | 3,887,592 | -1.7% | 0.24% | -7.5% |
| Q1 2021 | $333,449,000 | +1.3% | 3,953,630 | -3.6% | 0.25% | 0.0% |
| Q4 2020 | $329,199,000 | +1.3% | 4,102,676 | +1.6% | 0.25% | -12.1% |
| Q3 2020 | $324,887,000 | -4.8% | 4,039,881 | +1.9% | 0.29% | -14.0% |
| Q2 2020 | $341,241,000 | +13.3% | 3,963,313 | +6.8% | 0.34% | -7.9% |
| Q1 2020 | $301,171,000 | -4.6% | 3,709,458 | -1.7% | 0.36% | +27.6% |
| Q4 2019 | $315,622,000 | -4.9% | 3,774,478 | -0.5% | 0.29% | -13.3% |
| Q3 2019 | $331,765,000 | +10.7% | 3,792,899 | +3.6% | 0.33% | -6.8% |
| Q2 2019 | $299,755,000 | +13.5% | 3,660,014 | +12.7% | 0.35% | +8.6% |
| Q1 2019 | $264,145,000 | +47.7% | 3,248,612 | +19.6% | 0.33% | +29.9% |
| Q4 2018 | $178,818,000 | +17.4% | 2,716,768 | +37.4% | 0.25% | +28.1% |
| Q3 2018 | $152,373,000 | +13.5% | 1,976,555 | +8.7% | 0.20% | +5.4% |
| Q2 2018 | $134,284,000 | +36.2% | 1,818,578 | +19.9% | 0.19% | +32.9% |
| Q1 2018 | $98,629,000 | +3.7% | 1,516,440 | +3.1% | 0.14% | +8.5% |
| Q4 2017 | $95,095,000 | +4.5% | 1,471,145 | +1.4% | 0.13% | -4.4% |
| Q3 2017 | $91,003,000 | +7.1% | 1,450,242 | +3.4% | 0.14% | -0.7% |
| Q2 2017 | $84,948,000 | +9.5% | 1,403,166 | -6.2% | 0.14% | +7.1% |
| Q1 2017 | $77,612,000 | +15.2% | 1,496,566 | -1.5% | 0.13% | +12.4% |
| Q4 2016 | $67,395,000 | -12.5% | 1,519,966 | -6.0% | 0.11% | -11.0% |
| Q3 2016 | $76,991,000 | -17.3% | 1,617,467 | -21.5% | 0.13% | -15.9% |
| Q2 2016 | $93,138,000 | +53.6% | 2,059,667 | +39.5% | 0.15% | +54.1% |
| Q1 2016 | $60,656,000 | +8.1% | 1,476,523 | +0.4% | 0.10% | +10.1% |
| Q4 2015 | $56,108,000 | +16.1% | 1,470,723 | -0.0% | 0.09% | +8.5% |
| Q3 2015 | $48,330,000 | -54.3% | 1,471,223 | -2.8% | 0.08% | -48.4% |
| Q2 2015 | $105,820,000 | -11.0% | 1,513,223 | -10.1% | 0.16% | -3.0% |
| Q1 2015 | $118,924,000 | 0.0% | 1,683,048 | 0.0% | 0.16% | 0.0% |
| Q4 2014 | $118,924,000 | +12.4% | 1,683,048 | +14.2% | 0.16% | +12.3% |
| Q3 2014 | $105,811,000 | -2.8% | 1,474,302 | -2.1% | 0.15% | -1.4% |
| Q2 2014 | $108,832,000 | -5.3% | 1,505,278 | -5.3% | 0.15% | -9.8% |
| Q1 2014 | $114,978,000 | -0.2% | 1,590,291 | -4.3% | 0.16% | -0.6% |
| Q4 2013 | $115,247,000 | +17.0% | 1,662,543 | +10.9% | 0.16% | -9.3% |
| Q3 2013 | $98,470,000 | -4.1% | 1,499,009 | +1.2% | 0.18% | -11.7% |
| Q2 2013 | $102,644,000 | – | 1,481,793 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |